Gernandt & Danielsson advised Fidim in connection with the disposal of Rottapharm|Madaus group to Meda
The consideration comprised SEK 15.3 billion (EUR 1.643 billion) in cash, 30 million Meda shares corresponding to a value of SEK 3.3 billion (EUR 357 million) and a non-contingent deferred payment in January 2017 of SEK 2.6 billion (EUR 275 million). Following completion of the transaction, the Rovati family owns 9% of Meda.
Gernandt & Danielsson acted as legal advisor to Fidim S.r.l and the Rovati family (the shareholder of Fidim). The Gernandt Danielsson team included Partner Carl Westerberg and Senior Associate Leo Lee.Print